Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | TMO | VTRS |
|---|
| Close | 697.00 | 19.04 |
| Market Cap | $258B | $20.7B |
| 1M | +3.25% | +7.42% |
| P/E (TTM) | 36.4 | — |
| Forward P/E | 24.6 | 6.6 |
| P/E 5-Yr Percentile | 78 | — |
| P/S | 5.4 | 1.5 |
| P/B | 4.7 | 1.5 |
| Dividend Yield | 0.29% | 5.09% |
| Latest Quarter Revenue | $12.1B | $3.7B |
| Revenue YoY | +9.1% | +5.0% |
| Gross Margin | — | 38.6% |
| Latest Quarter EPS | 4.64 | -0.10 |
| Avg Post-Earnings Move | ±1.2% | ±1.9% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.82% | 1.47% |
| 90-Day Net Insider Buying | −$40.3M | — |
TMO · Revenue, Last 8 Quarters ($B)
VTRS · Revenue, Last 8 Quarters ($B)
